相关实验视频
Updated: Jun 26, 2025
05:43
Protocol for Developing a Femur Osteotomy Model in Wistar Albino Rats
Published on: August 31, 2022
2.7K
在二次骨折预防中检查治疗目标和骨活性药物使用的公平性:系统性审查和元分析
Anum Ali1, Ella Huszti2, Shahryar Noordin3
1Institute of Health Policy, Management and Evaluation, University of Toronto, 4th Floor - 155 College Street, Toronto, ON, M5T 3M6, Canada. Anum.asifhakimali@mail.utoronto.ca.
概括
这项研究发现,77%的脆弱性骨折患者被处方了骨活性药物,71%开始治疗. 标准化报告和股权分析对于改善二次骨折预防计划至关重要.
科学领域:
- 整形外科 整形外科 整形外科
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 脆弱性骨折对公众健康造成重大负担,需要有效的二次骨折预防.
- 二次骨折预防计划旨在通过药物治疗等干预措施降低随后骨折的风险.
- 在了解这些计划中的药理疗法的吸收和公平性方面存在差距.
研究的目的:
- 评估在二次骨折预防计划中,骨活性药物被指示,处方和启动的脆弱性骨折患者的比例.
- 基于人口和社会经济因素,分析药物治疗中的公平性.
- 确定骨折后护理和干预交付的改进领域.
主要方法:
- 对122项研究进行系统审查,包括114项二次骨折预防计划.
- 进行元分析,以确定药物处方和药物开始的聚合比例.
- 提取和分析与股权相关的变量,包括年龄,性别,种族,教育,收入和地理位置.
主要成果:
- 骨活性药物的综合处方率为77%,药物开始率为71%.
- 在骨折联络服务和其他项目类型之间没有观察到治疗开始的显著差异.
- 报告的公平性变量仅限于与治疗结果相关的年龄,性别和社会经济地位.
结论:
- 在骨折后的干预中,标准化报告准则是必不可少的,以确保统一的数据收集和评估.
- 将公平考虑纳入健康结果分析对于解决差距至关重要.
- 改善二次骨折预防计划需要专注于公平获得和提供药理疗法.
相关概念视频
01:27Fractures: Bone Repair
3.2K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.2K
01:29Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K
01:31Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
01:40Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
01:25Role of Vitamins in Maintaining Bone Health
3.3K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.3K
01:21Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K